Multiple Myeloma Market Analysis
The Multiple Myeloma market was valued at US$20.44 billion in 2023 and is projected to reach US$37.90 billion by 2032, with a compound annual growth rate (CAG...
Multiple myeloma is a type of blood cancer originating in plasma cells, a type of white blood cell found in bone marrow. Plasma cells play a crucial role in the immune system by producing antibodie...
